Julia L. Marcus, Ph.D. - Publications

Affiliations: 
2013 Epidemiology University of California, Berkeley, Berkeley, CA, United States 
Area:
Public Health, Epidemiology

97 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Lam JO, Leyden WA, Alexeeff S, Lea AN, Hechter RC, Hu H, Marcus JL, Pitts L, Yuan Q, Towner WJ, Horberg MA, Silverberg MJ. Changes in Body Mass Index Over Time in People With and Without HIV Infection. Open Forum Infectious Diseases. 11: ofad611. PMID 38323078 DOI: 10.1093/ofid/ofad611  0.344
2024 Irie WC, Calabrese SK, Mayer KH, Geng EH, Blackstock O, Marcus JL. Social and structural factors associated with interest in HIV preexposure prophylaxis among Black women in the United States. Aids Care. 1-10. PMID 38176016 DOI: 10.1080/09540121.2023.2299338  0.332
2023 Krakower D, Marcus JL. Commercial Determinants of Access to HIV Preexposure Prophylaxis. Jama Network Open. 6: e2342759. PMID 37948087 DOI: 10.1001/jamanetworkopen.2023.42759  0.475
2023 Chinbunchorn T, Mayer KH, Campbell J, Alm DK, Krakower D, Marcus JL, Grasso C, Keuroghlian AS. HIV pre-exposure prophylaxis provision by U.S. Health centers in 2021. Aids (London, England). PMID 37905992 DOI: 10.1097/QAD.0000000000003774  0.384
2023 Hechter RC, Zhou H, Leyden WA, Yuan Q, Pak KJ, Lam JO, Alexeeff S, Lea A, Hu H, Marcus JL, Rivera AS, Adams AL, Horberg MA, Towner WJ, Lo JC, et al. Fracture Risk and Association With TDF Use Among People With HIV in Large Integrated Health Systems. Journal of Acquired Immune Deficiency Syndromes (1999). 94: 341-348. PMID 37884055 DOI: 10.1097/QAI.0000000000003274  0.343
2023 Etami Y, Zaheer MA, Marcus JL, Calabrese SK. Accuracy of HIV Risk-Related Information and Inclusion of Undetectable = Untransmittable, Pre-Exposure Prophylaxis, and Post-Exposure Prophylaxis on US Health Department Websites. Aids Patient Care and Stds. 37: 425-427. PMID 37713285 DOI: 10.1089/apc.2023.0150  0.324
2023 Irie WC, Chitneni P, Glynn TR, Allen W, Chai PR, Engelman AN, Hurtado R, Li JZ, Li P, Lockman S, Marcus JL, Ogunshola FJ, Rönn MM, Haberer J, Ghebremichael M, et al. Pathways and Intersections: Multifaceted Approaches to Engage Individuals From Underrepresented and Marginalized Communities in HIV Research and Career Development. Journal of Acquired Immune Deficiency Syndromes (1999). 94: S116-S121. PMID 37707858 DOI: 10.1097/QAI.0000000000003265  0.398
2023 Traeger MW, Mayer KH, Krakower DS, Gitin S, Jenness SM, Marcus JL. Potential impact of doxycycline post-exposure prophylaxis prescribing strategies on incidence of bacterial sexually transmitted infections. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 37595139 DOI: 10.1093/cid/ciad488  0.425
2023 Traeger MW, Krakower DS, Mayer KH, Marcus JL. Prioritising the values of potential users to promote uptake of HIV pre-exposure prophylaxis. The Lancet. Hiv. PMID 37573870 DOI: 10.1016/S2352-3018(23)00171-6  0.345
2023 Krakower D, Marcus JL. Free the PrEP - Over-the-Counter Access to HIV Preexposure Prophylaxis. The New England Journal of Medicine. 389: 481-483. PMID 37548326 DOI: 10.1056/NEJMp2305644  0.472
2023 Sewak A, Lodi S, Li X, Shu D, Wen L, Mayer KH, Krakower DS, Young JG, Marcus JL. Causal effects of stochastic PrEP interventions on HIV incidence among men who have sex with men. American Journal of Epidemiology. PMID 37073419 DOI: 10.1093/aje/kwad097  0.44
2022 Burns CM, Pung L, Witt D, Gao M, Sendak M, Balu S, Krakower D, Marcus JL, Okeke NL, Clement ME. Development of an HIV Risk Prediction Model Using Electronic Health Record Data from an Academic Health System in the Southern United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36125084 DOI: 10.1093/cid/ciac775  0.403
2022 Marcus JL, Killelea A, Krakower DS. HIV Prevention and the 340B Drug Pricing Program. Reply. The New England Journal of Medicine. 387: 576. PMID 35947725 DOI: 10.1056/NEJMc2208621  0.335
2022 Mann LM, Le Guillou A, Goodreau SM, Marcus JL, Sanchez T, Weiss KM, Jenness SM. Correlations between community-level HIV preexposure prophylaxis coverage and individual-level sexual behaviors among US men who have sex with men. Aids (London, England). PMID 35876641 DOI: 10.1097/QAD.0000000000003343  0.371
2022 Marcus JL, Killelea A, Krakower DS. Perverse Incentives - HIV Prevention and the 340B Drug Pricing Program. The New England Journal of Medicine. 386: 2064-2066. PMID 35621521 DOI: 10.1056/NEJMp2200601  0.334
2022 Irie WC, Calabrese SK, Patel RR, Mayer KH, Geng EH, Marcus JL. Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.S. Aids and Behavior. PMID 34985607 DOI: 10.1007/s10461-021-03571-8  0.411
2021 Willis SJ, Kim HN, Achenbach CJ, Cachay ER, Christopoulos KA, Crane HM, Franco RA, Hurt CB, Kitahata MM, Moore RD, Silverberg MJ, Tien PC, Westreich D, Marcus JL. Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV. Hiv Medicine. PMID 34951105 DOI: 10.1111/hiv.13218  0.372
2021 Young-Wolff KC, Marcus JL, Satre DD. Cannabis Use and Patient-Centered Care During Pregnancy and Post Partum Among People Living With HIV. Jama Network Open. 4: e2137588. PMID 34860248 DOI: 10.1001/jamanetworkopen.2021.37588  0.345
2021 Hojilla JC, Hurley LB, Marcus JL, Satre DD, Silverberg MJ, Zaritsky EF, Getahun D, Goodman M, Volk JE. The HIV preexposure prophylaxis (PrEP) continuum of care among transgender individuals in an integrated healthcare system. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 34723924 DOI: 10.1097/QAI.0000000000002853  0.412
2021 Marcus JL, Levine K, Sewell WC, Solleveld P, Mayer KH, Krakower DS. Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide for Human Immunodeficiency Virus Preexposure Prophylaxis at a Boston Community Health Center. Open Forum Infectious Diseases. 8: ofab372. PMID 34631926 DOI: 10.1093/ofid/ofab372  0.334
2021 Hojilla JC, Hurley LB, Marcus JL, Silverberg MJ, Skarbinski J, Satre DD, Volk JE. Characterization of HIV Preexposure Prophylaxis Use Behaviors and HIV Incidence Among US Adults in an Integrated Health Care System. Jama Network Open. 4: e2122692. PMID 34436609 DOI: 10.1001/jamanetworkopen.2021.22692  0.423
2021 Sewell WC, Powell VE, Ball-Burack M, Mayer KH, Ochoa A, Marcus JL, Krakower DS. Brief Report: "I Didn't Really Have a Primary Care Provider Until I Got PrEP": Patients' Perspectives on HIV Preexposure Prophylaxis as a Gateway to Health Care. Journal of Acquired Immune Deficiency Syndromes (1999). 88: 31-35. PMID 34397743 DOI: 10.1097/QAI.0000000000002719  0.367
2021 Manza-A Agovi A, Anikpo I, Cvitanovich M, Fasanmi EO, Ojha RP, Marcus JL. Brief Report: HIV Pre-Exposure Prophylaxis Prescribing in an Urban Safety-Net Health System. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 34285157 DOI: 10.1097/QAI.0000000000002767  0.374
2021 Jenness SM, Knowlton G, Smith DK, Marcus JL, Anderson EJ, Siegler AJ, Jones J, Sullivan PS, Enns E. A decision analytics model to optimize investment in interventions targeting the HIV PrEP cascade of care. Aids (London, England). PMID 33831910 DOI: 10.1097/QAD.0000000000002909  0.391
2021 Calabrese SK, Mayer KH, Marcus JL. Prioritising pleasure and correcting misinformation in the era of U=U. The Lancet. Hiv. 8: e175-e180. PMID 33662266 DOI: 10.1016/S2352-3018(20)30341-6  0.457
2021 Marcus JL, Sewell WC, Powell VE, Ochoa A, Mayer KH, Krakower DS. HIV Preexposure Prophylaxis and Sexual Satisfaction Among Men Who Have Sex with Men. Sexually Transmitted Diseases. PMID 33657578 DOI: 10.1097/OLQ.0000000000001361  0.335
2021 Jenness SM, Le Guillou A, Chandra C, Mann LM, Sanchez T, Westreich D, Marcus JL. Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption. The Journal of Infectious Diseases. PMID 33507308 DOI: 10.1093/infdis/jiab051  0.466
2021 Coburn SB, Shiels M, Silverberg M, Horberg M, Gill MJ, Brown TT, Visvanathan K, Connor AE, Napravnik S, Marcus J, Moore RD, Mathews WC, Mayor AM, Sterling T, Li J, et al. Secular Trends in Breast Cancer Risk among Women with HIV Initiating ART in North America. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 33492023 DOI: 10.1097/QAI.0000000000002627  0.325
2021 Rao A, Rucinski K, Jarrett B, Ackerman B, Wallach S, Marcus J, Adamson T, Garner A, Santos GM, Beyrer C, Howell S, Baral S. Perceived interruptions to HIV prevention and treatment services associated with COVID-19 for gay, bisexual, and other men who have sex with men in 20 countries. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 33443963 DOI: 10.1097/QAI.0000000000002620  0.441
2020 Sewell WC, Patel RR, Blankenship S, Marcus JL, Krakower DS, Chan PA, Parker K. Associations Among HIV Risk Perception, Sexual Health Efficacy, and Intent to Use PrEP Among Women: An Application of the Risk Perception Attitude Framework. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 32: 392-402. PMID 33112674 DOI: 10.1521/aeap.2020.32.5.392  0.353
2020 Jenness SM, Le Guillou A, Chandra C, Mann LM, Sanchez T, Westreich D, Marcus JL. Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption. Medrxiv : the Preprint Server For Health Sciences. PMID 33024979 DOI: 10.1101/2020.09.30.20204529  0.444
2020 Chandra C, Weiss KM, Kelley CF, Marcus JL, Jenness SM. Gaps in Sexually Transmitted Infection Screening among Men who Have Sex with Men in PrEP Care in the United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32702116 DOI: 10.1093/Cid/Ciaa1033  0.469
2020 Krakower DS, Daskalakis DC, Feinberg J, Marcus JL. Tenofovir Alafenamide for HIV Preexposure Prophylaxis. Annals of Internal Medicine. 173: 78. PMID 32628873 DOI: 10.7326/L20-0301  0.558
2020 Marcus JL, Leyden WA, Alexeeff SE, Anderson AN, Hechter RC, Hu H, Lam JO, Towner WJ, Yuan Q, Horberg MA, Silverberg MJ. Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016. Jama Network Open. 3: e207954. PMID 32539152 DOI: 10.1001/jamanetworkopen.2020.7954  0.443
2020 Hojilla JC, Marcus JL, Silverberg MJ, Hare CB, Herbers R, Hurley L, Satre DD, Volk JE. Early Adopters of Event-driven Human Immunodeficiency Virus Pre-exposure Prophylaxis in a Large Healthcare System in San Francisco. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32494806 DOI: 10.1093/Cid/Ciaa474  0.514
2020 Marcus JL, Sewell WC, Balzer LB, Krakower DS. Artificial Intelligence and Machine Learning for HIV Prevention: Emerging Approaches to Ending the Epidemic. Current Hiv/Aids Reports. PMID 32347446 DOI: 10.1007/S11904-020-00490-6  0.434
2020 Sewell WC, Powell VE, Mayer KH, Ochoa A, Krakower DS, Marcus JL. Non-Daily Use of HIV Preexposure Prophylaxis in a Large Online Survey of Primarily Men Who Have Sex with Men in the U.S. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 32168169 DOI: 10.1097/Qai.0000000000002332  0.506
2020 Katz KA, Park AJ, Marcus JL. Preexposure Prophylaxis for Human Immunodeficiency Virus Infection for Men Who Have Sex with Men and Transgender Persons:: What Dermatologists Need to Know. Dermatologic Clinics. 38: 233-238. PMID 32115133 DOI: 10.1016/J.Det.2019.10.008  0.596
2020 Willis SJ, Elder H, Cocoros N, Young J, Marcus JL, Eberhardt K, Callahan M, Herrick B, Weiss M, Hafer E, Erani D, Josephson M, Llata E, Flagg EW, Hsu KK, et al. More Screening or More Disease? Gonorrhea Testing and Positivity Patterns among Men in Three Large Clinical Practices in Massachusetts, 2010-2017. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31967644 DOI: 10.1093/Cid/Ciaa066  0.31
2020 Krakower DS, Daskalakis DC, Feinberg J, Marcus JL. Tenofovir Alafenamide for HIV Preexposure Prophylaxis: What Can We DISCOVER About Its True Value? Annals of Internal Medicine. PMID 31931525 DOI: 10.7326/M19-3337  0.512
2019 Krakower DS, Marcus JL. Machine learning for HIV prevention in rural Africa: the SEARCH for sustainability. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31697379 DOI: 10.1093/Cid/Ciz1101  0.445
2019 Hojilla JC, Marcus J, Volk JE, Leyden W, Hare CB, Hechter RC, Edelman EJ, Silverberg M, Satre DD. Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV. Sexually Transmitted Infections. PMID 31444278 DOI: 10.1136/Sextrans-2019-054049  0.441
2019 Marcus JL, Snowden JM, Murray Horwitz ME, Toh S, Horgan C, Tilney RC, Rajbhandari R, Back S, Westreich DJ. Use of Intrauterine Devices and Risk of HIV Acquisition among Insured Women in the U.S. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31412356 DOI: 10.1093/Cid/Ciz791  0.478
2019 Marcus JL, Krakower DS. Working Toward Broad and Equitable Access to HIV Preexposure Prophylaxis. American Journal of Public Health. 109: 1160-1161. PMID 31390256 DOI: 10.2105/Ajph.2019.305254  0.538
2019 Marcus JL, Hurley LB, Krakower DS, Alexeeff S, Silverberg MJ, Volk JE. Use of electronic health record data and machine learning to identify candidates for HIV pre-exposure prophylaxis: a modelling study. The Lancet. Hiv. PMID 31285183 DOI: 10.1016/S2352-3018(19)30137-7  0.505
2019 Gilkey MB, Marcus JL, Garrell JM, Powell VE, Maloney KM, Krakower DS. Using HIV Risk Prediction Tools to Identify Candidates for Pre-exposure Prophylaxis: Perspectives from Patients and Primary Care Providers. Aids Patient Care and Stds. PMID 31210551 DOI: 10.1089/Apc.2019.0056  0.512
2019 Lam JO, Hurley LB, Chamberland S, Champsi JH, Gittleman LC, Korn DG, Lai JB, Quesenberry CP, Ready J, Saxena V, Seo SI, Witt DJ, Silverberg MJ, Marcus JL. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system. International Journal of Std & Aids. 956462419836520. PMID 31046611 DOI: 10.1177/0956462419836520  0.426
2019 Krakower D, Maloney KM, Powell VE, Levine K, Grasso C, Melbourne K, Marcus JL, Mayer KH. Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care. Journal of the International Aids Society. 22: e25250. PMID 30768762 DOI: 10.1002/Jia2.25250  0.487
2019 Marcus JL, Katz KA, Krakower DS, Calabrese SK. Risk Compensation and Clinical Decision Making - The Case of HIV Preexposure Prophylaxis. The New England Journal of Medicine. 380: 510-512. PMID 30726699 DOI: 10.1056/Nejmp1810743  0.464
2018 Marcus JL, Hurley LB, Dentoni-Lasofsky D, Ellis CG, Silverberg MJ, Slome S, Snowden JM, Volk JE. Barriers to preexposure prophylaxis use among individuals with recently acquired HIV infection in Northern California. Aids Care. 1-9. PMID 30304942 DOI: 10.1080/09540121.2018.1533238  0.589
2018 Rosenberg ES, Marcus JL. Progress and pitfalls in measuring HIV preexposure prophylaxis coverage in the United States. Annals of Epidemiology. PMID 30224292 DOI: 10.1016/J.Annepidem.2018.08.005  0.49
2018 Marcus JL, Hurley LB, Prasad A, Zaroff J, Klein DB, Horberg MA, Go AS, DeLorenze GN, Quesenberry CP, Sidney S, Lo JC, Silverberg MJ. Recurrence after hospitalization for acute coronary syndrome among HIV-infected and HIV-uninfected individuals. Hiv Medicine. PMID 30178911 DOI: 10.1111/Hiv.12670  0.521
2018 Guinness RR, Volk JE, Hurley LB, Tobias TT, Marcus JL. Low-Intensity Outreach to Increase Uptake of HIV Preexposure Prophylaxis Among Patients with Sexually Transmitted Infections. Aids and Behavior. PMID 30101394 DOI: 10.1007/S10461-018-2245-8  0.467
2018 Marcus JL, Levine K, Grasso C, Krakower DS, Powell V, Bernstein KT, Boswell S, Mayer KH. HIV Preexposure Prophylaxis as a Gateway to Primary Care. American Journal of Public Health. e1-e3. PMID 30024802 DOI: 10.2105/Ajph.2018.304561  0.54
2018 Rhee SY, Clutter D, Fessel WJ, Klein D, Slome S, Pinsky BA, Marcus JL, Hurley L, Silverberg MJ, Kosakovsky Pond SL, Shafer RW. Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance in a Large U.S. Clinic Population. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29846534 DOI: 10.1093/Cid/Ciy453  0.318
2018 Marcus JL, Volk JE, Snowden JM. Concerns about a study on sexually transmitted infections after initiation of HIV preexposure prophylaxis. Aids (London, England). 32: 955-956. PMID 29578895 DOI: 10.1097/Qad.0000000000001769  0.543
2017 Volk JE, Nguyen DP, Hare CB, Marcus JL. HIV Infection and Drug Resistance with Unsupervised Use of HIV Preexposure Prophylaxis. Aids Research and Human Retroviruses. PMID 29262689 DOI: 10.1089/Aid.2017.0285  0.551
2017 Marcus JL, Hurley LB, Nguyen DP, Silverberg MJ, Volk JE. Redefining HIV Preexposure Prophylaxis Failures. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29020235 DOI: 10.1093/Cid/Cix593  0.513
2017 Storholm ED, Volk JE, Marcus JL, Silverberg MJ, Satre DD. Risk Perception, Sexual Behaviors, and PrEP Adherence Among Substance-Using Men Who Have Sex with Men: a Qualitative Study. Prevention Science : the Official Journal of the Society For Prevention Research. PMID 28578516 DOI: 10.1007/S11121-017-0799-8  0.521
2017 Marcus JL, Leyden WA, Chao CR, Horberg MA, Klein DB, Quesenberry CP, Towner WJ, Silverberg MJ. Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals. Aids (London, England). PMID 28252529 DOI: 10.1097/Qad.0000000000001434  0.483
2016 Marcus JL, Hurley LB, Hare CB, Nguyen DP, Phengrasamy T, Silverberg MJ, Stoltey JE, Volk JE. Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation. Journal of Acquired Immune Deficiency Syndromes (1999). 73: 540-546. PMID 27851714 DOI: 10.1097/Qai.0000000000001129  0.493
2016 Marcus JL, Baxter R, Leyden WA, Muthulingam D, Yee A, Horberg MA, Klein DB, Towner WJ, Chao CR, Quesenberry CP, Silverberg MJ. Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System. Aids Patient Care and Stds. 30: 463-470. PMID 27749111 DOI: 10.1089/Apc.2016.0165  0.579
2016 Marcus JL, Hurley LB, Hare CB, Silverberg MJ, Volk JE. Disparities in Uptake of HIV Preexposure Prophylaxis in a Large Integrated Health Care System. American Journal of Public Health. 106: e2-3. PMID 27626355 DOI: 10.2105/Ajph.2016.303339  0.508
2016 Snowden JM, Rodriguez MI, Jackson SD, Marcus JL. Preexposure Prophylaxis and Patient Centeredness: A Call for Holistically Protecting and Promoting the Health of Gay Men. American Journal of Men's Health. PMID 27387042 DOI: 10.1177/1557988316658288  0.417
2016 Marcus JL, Chao CR, Leyden WA, Xu L, Quesenberry CP, Klein DB, Towner WJ, Horberg MA, Silverberg MJ. Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27028501 DOI: 10.1097/Qai.0000000000001014  0.561
2016 Marcus JL, Volk JE, Pinder J, Liu AY, Bacon O, Hare CB, Cohen SE. Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings. Current Hiv/Aids Reports. PMID 26898645 DOI: 10.1007/S11904-016-0308-X  0.496
2015 Marcus JL, Neugebauer RS, Leyden WA, Chao CR, Xu L, Quesenberry CP, Klein DB, Towner WJ, Horberg MA, Silverberg MJ. Use of abacavir and risk of cardiovascular disease among HIV-infected individuals. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26536316 DOI: 10.1097/Qai.0000000000000881  0.513
2015 Volk JE, Marcus JL, Phengrasamy T, Blechinger D, Nguyen DP, Follansbee S, Hare CB. No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 61: 1601-3. PMID 26334052 DOI: 10.1093/Cid/Civ778  0.565
2015 Marcus JL, Leyden WA, Chao CR, Xu L, Quesenberry CP, Tien PC, Klein DB, Towner WJ, Horberg MA, Silverberg MJ. Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status. Aids Patient Care and Stds. 29: 370-8. PMID 26061798 DOI: 10.1089/Apc.2015.0040  0.534
2015 Marcus JL, Chao C, Leyden WA, Xu L, Yu J, Horberg MA, Klein D, Towner WJ, Quesenberry CP, Abrams DI, Silverberg MJ. Survival Among HIV-Infected and HIV-Uninfected Individuals with Common Non-AIDS-Defining Cancers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 25713023 DOI: 10.1158/1055-9965.Epi-14-1079  0.549
2015 Volk JE, Marcus JL, Phengrasamy T, Hare CB. Incident Hepatitis C Virus Infections Among Users of HIV Preexposure Prophylaxis in a Clinical Practice Setting. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 1728-9. PMID 25694649 DOI: 10.1093/Cid/Civ129  0.42
2015 Klein DB, Leyden WA, Xu L, Chao CR, Horberg MA, Towner WJ, Hurley LB, Marcus JL, Quesenberry CP, Silverberg MJ. Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 1278-80. PMID 25595743 DOI: 10.1093/Cid/Civ014  0.551
2014 Marcus JL, Leyden WA, Chao CR, Chow FC, Horberg MA, Hurley LB, Klein DB, Quesenberry CP, Towner WJ, Silverberg MJ. HIV infection and incidence of ischemic stroke. Aids (London, England). 28: 1911-9. PMID 24937309 DOI: 10.1097/Qad.0000000000000352  0.444
2014 Amico KR, Marcus JL, McMahan V, Liu A, Koester KA, Goicochea P, Anderson PL, Glidden D, Guanira J, Grant R. Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 530-7. PMID 24853306 DOI: 10.1097/Qai.0000000000000216  0.348
2014 Marcus JL, Chao CR, Leyden WA, Xu L, Klein DB, Horberg MA, Towner WJ, Quesenberry CP, Abrams DI, Van Den Eeden SK, Silverberg MJ. Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 495-502. PMID 24820107 DOI: 10.1097/Qai.0000000000000202  0.521
2014 Marcus JL, Glidden DV, McMahan V, Lama JR, Mayer KH, Liu AY, Montoya-Herrera O, Casapia M, Hoagland B, Grant RM. Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men. Plos One. 9: e91513. PMID 24637511 DOI: 10.1371/Journal.Pone.0091513  0.43
2014 Marcus JL, Buisker T, Horvath T, Amico KR, Fuchs JD, Buchbinder SP, Grant RM, Liu AY. Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions. Hiv Medicine. 15: 385-95. PMID 24580813 DOI: 10.1111/Hiv.12132  0.514
2013 Marcus JL, Glidden DV, Mayer KH, Liu AY, Buchbinder SP, Amico KR, McMahan V, Kallas EG, Montoya-Herrera O, Pilotto J, Grant RM. No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. Plos One. 8: e81997. PMID 24367497 DOI: 10.1371/Journal.Pone.0081997  0.46
2013 Bernstein KT, Marcus JL, Barry PM, Pandori MW, Buono S, Hess D, Philip SS. Characteristics of males infected with common Neisseria gonorrhoeae sequence types in the Gonococcal Isolate Surveillance Project, San Francisco, California, 2009. American Journal of Epidemiology. 178: 1289-95. PMID 24049157 DOI: 10.1093/Aje/Kwt115  0.311
2013 Chen MJ, Pipkin S, Marcus JL, Bernstein KT, Scheer S. Using HIV testing history to measure the success of HIV partner services. Sexually Transmitted Diseases. 40: 419-21. PMID 23588133 DOI: 10.1097/Olq.0B013E318283Bfcb  0.649
2013 Chesson HW, Bernstein KT, Gift TL, Marcus JL, Pipkin S, Kent CK. The cost-effectiveness of screening men who have sex with men for rectal chlamydial and gonococcal infection to prevent HIV Infection. Sexually Transmitted Diseases. 40: 366-71. PMID 23588125 DOI: 10.1097/Olq.0B013E318284E544  0.672
2012 Park J, Marcus JL, Pandori M, Snell A, Philip SS, Bernstein KT. Sentinel surveillance for pharyngeal chlamydia and gonorrhea among men who have sex with men--San Francisco, 2010. Sexually Transmitted Diseases. 39: 482-4. PMID 22592836 DOI: 10.1097/Olq.0B013E3182495E2F  0.48
2012 R Amico K, McMahan V, Goicochea P, Vargas L, Marcus JL, Grant RM, Liu A. Supporting study product use and accuracy in self-report in the iPrEx study: next step counseling and neutral assessment. Aids and Behavior. 16: 1243-59. PMID 22460228 DOI: 10.1007/S10461-012-0182-5  0.347
2011 Marcus JL, Bernstein KT, Kohn RP, Liska S, Philip SS. Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men. Sexually Transmitted Diseases. 38: 922-4. PMID 21934565 DOI: 10.1097/Olq.0B013E31822A2B2E  0.367
2011 Marcus JL, Kohn RP, Barry PM, Philip SS, Bernstein KT. Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the female oropharynx to the male urethra. Sexually Transmitted Diseases. 38: 372-3. PMID 21183864 DOI: 10.1097/Olq.0B013E3182029008  0.342
2011 Katz KA, Lee MA, Gray T, Marcus JL, Pierce EF. Repeat syphilis among men who have sex with men--San Diego County, 2004-2009. Sexually Transmitted Diseases. 38: 349-52. PMID 21099734 DOI: 10.1097/Olq.0B013E3181Fe650B  0.476
2011 Marcus JL, Katz KA, Bernstein KT, Nieri G, Philip SS. Syphilis testing behavior following diagnosis with early syphilis among men who have sex with men--San Francisco, 2005-2008. Sexually Transmitted Diseases. 38: 24-9. PMID 20679965 DOI: 10.1097/Olq.0B013E3181Ea170B  0.387
2011 Park J, Marcus J, Bernstein K, Pandori M, Snell A, Philip S. P1-S2.41 Sentinel survillance for pharyngeal chlamydia and gonorrhoea among men who have sex with men - San Francisco, 2010 Sexually Transmitted Infections. 87: A140-A140. DOI: 10.1136/Sextrans-2011-050108.98  0.536
2011 Gift T, Bernstein K, Chesson H, Marcus J, Pipkin S, Kent C. P2-S6.11 The cost-effectiveness of screening men who have sex with men for rectal chlamydial and gonococcal infection to prevent HIV infection Sexually Transmitted Infections. 87. DOI: 10.1136/Sextrans-2011-050108.363  0.533
2011 Marcus JL, Bernstein KT, Philip SS. P2-S3.01 STI risk among persons attending burning man in 2010 Sexually Transmitted Infections. 87: A236-A237. DOI: 10.1136/Sextrans-2011-050108.320  0.349
2011 Bernstein K, Hjord H, Marcus J, Kohn R, Philip S. P1-S5.08 Attendance at local and national sex-events associated with STD diagnosis, San Francisco, 2010 Sexually Transmitted Infections. 87: A177-A178. DOI: 10.1136/Sextrans-2011-050108.186  0.329
2010 Marcus JL, Bernstein KT, Stephens SC, Snell A, Kohn RP, Liska S, Klausner JD. Sentinel surveillance of rectal chlamydia and gonorrhea among males--San Francisco, 2005-2008. Sexually Transmitted Diseases. 37: 59-61. PMID 20118677 DOI: 10.1097/Olq.0B013E3181B76C42  0.315
2010 Bernstein KT, Marcus JL, Nieri G, Philip SS, Klausner JD. Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. Journal of Acquired Immune Deficiency Syndromes (1999). 53: 537-43. PMID 19935075 DOI: 10.1097/Qai.0B013E3181C3Ef29  0.577
2010 Marcus JL, Katz MH, Katz KA, Bernstein KT, Wolf W, Klausner JD. Prediction model to maximize impact of syphilis partner notification--San Francisco, 2004-2008. Sexually Transmitted Diseases. 37: 109-14. PMID 19823113 DOI: 10.1097/Olq.0B013E3181Bbf985  0.318
2009 Marcus JL, Bernstein KT, Philip S, Klausner JD. Evidence of underreporting of adverse childhood experiences, San Francisco municipal STD clinic, 2007. Sexually Transmitted Diseases. 36: 422-4. PMID 19390496 DOI: 10.1097/Olq.0B013E31819D72Ad  0.546
2009 Marcus JL, Bernstein KT, Klausner JD. Updated outcomes of partner notification for human immunodeficiency virus, San Francisco, 2004-2008. Aids (London, England). 23: 1024-6. PMID 19293685 DOI: 10.1097/Qad.0B013E32832921A7  0.547
2009 Zetola NM, Bernstein K, Ahrens K, Marcus JL, Philip S, Nieri G, Jones D, Hare CB, Hsu L, Scheer S, Klausner JD. Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007 Bmc Public Health. 9. PMID 19144168 DOI: 10.1186/1471-2458-9-17  0.665
Show low-probability matches.